Philadelphia
November 2, 2023: TBD
May 24, 2023: Successes & Challenges in the Science of Cell & Gene Therapies
Mike Cohen, Managing Partner, Osage University Partners
Tracy Dowling, General Counsel & Head of BD, AskBio
John Maris, Co-Founder, Hulu Therapeutics & Division of Oncology, CHOP
Dan Takefman, former Head of Regulatory Affairs, Spark Therapeutics & former Chief of
Gene Therapy Branch, US FDA
Moderated by Kendra Rose, SVP & Head of BD & L, OI New Platforms, Cardiovascular &
Immunology, Bayer Pharmaceuticals